Structurally optimised BODIPY derivatives for imaging of mitochondrial dysfunction in cancer and heart cells.
The structural features required for mitochondrial uptake of BODIPY-based optical imaging agents have been explored. The first derivatives of this class of dyes shown to have mitochondrial membrane potential-dependent uptake in both cancer and heart cells have been developed.